JUN and hepatocellular carcinoma: Furthermore, FAM83A is upregulated in hepatocellular carcinoma and correlates with poor progression-free survival, and induces migration, invasion and metastasis of the tumor cells by activating EMT signaling and forming a FAM83A/PI3K/AKT/c-JUN positive-feedback loop [34].